Status:
COMPLETED
Study of Glycemic Control on Liver Transplantation Outcomes
Lead Sponsor:
Northwestern University
Conditions:
Evidence of Liver Transplantation
Hyperglycemia
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Many but not all studies have shown improvement in morbidity and mortality with intensive glycemic management postoperatively. In this study, the investigators propose to determine whether improved gl...
Detailed Description
Many studies have shown improvement in morbidity and mortality with intensive glycemic management postoperatively. However, some recent studies have not been able to reproduce these benefits and have ...
Eligibility Criteria
Inclusion
- Require Liver Transplantation
- Age 18 - 80
- Able to give informed consent personally or via a family member who has appropriate authorization to do so if patient unconscious.
- Expected survival following transplantation for \> 1 year.
- Glucose level over 180 mg/dL postoperatively
Exclusion
- Inability of patient or family member to give informed consent
- Not expected to survive for \> 1 year following liver transplantation.
- Previous liver transplantation
- Acute liver failure
- Living related donor
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT01211730
Start Date
April 1 2009
End Date
May 1 2016
Last Update
December 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States, 60611